CTOs on the Move

Apollo Endosurgery

www.apolloendo.com

 
Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal conditions. Apollo`s device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo`s products are offered in over 70 countries today and include the OverStitch™ Endoscopic Suturing System, the X-Tack™ Endoscopic HeliX Tacking System, and the ORBERA® Intragastric Balloon.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.apolloendo.com
  • 1120 South Capital of Texas Highway Building 1, Suite 300
    Austin, TX USA 78746
  • Phone: 512.279.5100

Executives

Name Title Contact Details

Funding

Apollo Endosurgery raised $23.7M on 06/22/2018

Similar Companies

American Disabilities Corporation

American Disabilities Corporation is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Guided Therapeutics

Guided Therapeutics, Inc is a Norcross, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lab Water Purification System from Aqua Solutions

Lab Water Purification System from Aqua Solutions is a Jasper, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CMA MICRODIALYSIS

CMA MICRODIALYSIS is a North Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novarix

Novarix is a collaborative medical device development company based near Oxford, UK and Raleigh, North Carolina, USA, delivering innovative new products in the field of venepuncture and cannulation to the worldwide healthcare sector. Novarix are proud to bring to market the IV-eye® – a portable, near infrared (NIR) vein imaging device which demonstrates the company ethos of practicality, simplicity and performance for both healthcare professionals and patients. The product idea came from a nursing perspective and has been developed in consultation with medical professionals in the UK and Denmark and with assistance from the biomedical engineering departments of Oxford University and University College London.